Bioavailability of sodium cyanate in patients with sickle cell disease and the lack of inhibition in vitro of globin synthesis at in vivo concentrations of cyanate.

Nigen, A M

Bioavailability of sodium cyanate in patients with sickle cell disease and the lack of inhibition in vitro of globin synthesis at in vivo concentrations of cyanate. [electronic resource] - The Journal of pharmacology and experimental therapeutics Nov 1975 - 333-9 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0022-3565


Anemia, Sickle Cell--drug therapy
Antacids
Biological Availability
Capsules
Cyanates--administration & dosage
Dose-Response Relationship, Drug
Gelatin
Globins--biosynthesis
Humans
Suppositories
Time Factors